This report contains market size and forecasts of Influenza Drugs and Vaccines in global, including the following market information:
- Global Influenza Drugs and Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Influenza Drugs and Vaccines Market Sales, 2017-2022, 2023-2028, (MT)
- Global top five Influenza Drugs and Vaccines companies in 2021 (%)
The global Influenza Drugs and Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Influenza Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Influenza Drugs and Vaccines include Bristol Myers Squibb, AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Influenza Drugs and Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Drugs and Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, by Type, 2021 (%)
- Influenza Drugs
- Influenza Vaccines
Global Influenza Drugs and Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Influenza Drugs and Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Influenza Drugs and Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Influenza Drugs and Vaccines revenues share in global market, 2021 (%)
- Key companies Influenza Drugs and Vaccines sales in global market, 2017-2022 (Estimated), (MT)
- Key companies Influenza Drugs and Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol Myers Squibb
- AstraZeneca
- Eli Lilly
- Roche
- GlaxoSmithKline
- Novartis
- Pfizer
- Sanofi Pasteur
- Bayer
- Celgene
- Seqirus
- Protein Sciences Corporation
- Serum Institute of India
- Emergent Biosolutions
- BioCryst Pharmaceuticals
- Alvogen
